Full-Time

Full-Stack Software Engineer

Confirmed live in the last 24 hours

Probably Genetic

Probably Genetic

11-50 employees

Provides free at-home genetic testing services

Biotechnology
Healthcare

Compensation Overview

$150k - $189kAnnually

Junior, Mid

San Francisco, CA, USA

Hybrid position with flexible work; requires some in-office presence.

Category
Full-Stack Engineering
Software Engineering
Required Skills
Python
React.js
Postgres
GraphQL
TypeScript
AWS
Terraform
Django
Requirements
  • Extensive experience in software development (including experience working on full stack code bases)
  • Experience with solving key infrastructure challenges as a business scales and grows
  • Experience in a range of software languages and frameworks including our tech stack.
  • Languages: Python (Django) and Typescript
  • Frameworks: React, GraphQL
  • Others: PostgreSQL, AWS, Terraform, GitHub Actions
  • Experience designing and building scalable systems used by external users
  • Track-record of solving extremely difficult, ambiguous problems
Responsibilities
  • Create APIs, laboratory integrations, bioinformatic tooling, and ML infrastructure using Python, Django, PostgreSQL databases, and AWS services
  • Develop the phenotyping product and biotech data platform frontends in React & Typescript
  • Regularly review your team’s code and technical documentation to maintain high standards and architectural quality
  • Present your work to relevant stakeholders, monitoring outcomes, and integrating patient feedback
  • Contribute to a culture of continuous improvement at a high velocity by optimizing development processes
  • Own business goals and writing technical design specifications to find more patients, grow revenue, and increase margins
  • Collaborate with the Growth and Business Development teams to implement solutions which drive customer value and growth
  • Work with cross-functional stakeholders to refine business processes and develop software to automate those processes

Probably Genetic provides genetic testing services specifically for individuals with rare diseases. Their main offering is a free at-home genetic testing kit, which allows patients to collect DNA samples conveniently from their homes. After the samples are sent back, the company analyzes the DNA to help patients receive accurate diagnoses and genetic counseling. Unlike many competitors, Probably Genetic operates its program at no cost to eligible patients by funding it themselves and managing all data collected. This data, once de-identified, can be shared with research institutions and pharmaceutical companies, creating a revenue stream for the company. The goal of Probably Genetic is to assist patients in overcoming the challenges of obtaining timely and accurate diagnoses for rare diseases while also contributing to research in this critical area.

Company Stage

Seed

Total Funding

$10.6M

Headquarters

San Francisco, California

Founded

2019

Growth & Insights
Headcount

6 month growth

47%

1 year growth

181%

2 year growth

287%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnerships with foundations like SCN2A and APBD Research Foundation enhance Probably Genetic's credibility and expand access to their services.
  • The free at-home testing model lowers barriers for patients, potentially leading to higher adoption rates and more comprehensive data collection.
  • The company’s innovative approach to data monetization can attract significant interest from research institutions and pharmaceutical companies.

What critics are saying

  • Reliance on data monetization could raise ethical concerns and potential regulatory scrutiny.
  • The niche focus on rare diseases may limit market size and growth potential.

What makes Probably Genetic unique

  • Probably Genetic offers free at-home genetic testing, a unique approach in the genetic testing market, particularly for rare diseases.
  • Their business model of monetizing de-identified patient data for research purposes provides a sustainable revenue stream while advancing rare disease research.
  • The company’s focus on rare diseases fills a critical gap in the healthcare system, offering timely and accurate diagnoses that are often hard to obtain.

Help us improve and share your feedback! Did you find this helpful?